financial statements
The full income statement, balance sheet, and cash-flow statement for GE HealthCare Technologies Inc. Common Stock (GEHC), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 20.6B YoY+4.8% | 19.7B YoY+0.6% | 19.6B YoY+6.6% | 18.3B YoY+4.3% | 17.6B | |
| Gross profit | 8.25B YoY+0.5% | 8.21B YoY+3.6% | 7.92B YoY+10.3% | 7.18B YoY+0.1% | 7.17B | |
5.49B YoY-1.7% | 5.58B YoY+1.7% | 5.49B YoY+17.8% | 4.66B YoY+6.3% | 4.38B | ||
| Operating income | 2.76B YoY+5.3% | 2.63B YoY+7.8% | 2.44B YoY-3.4% | 2.52B YoY-9.8% | 2.79B | |
| Other non-operating income | 157M YoY+185.5% | 55.0M YoY-36.0% | 86.0M YoY+38.7% | 62.0M YoY-49.6% | 123M | |
| Equity-method income | 3.00M YoY-62.5% | 8.00M YoY-27.3% | 11.0M YoY-15.4% | 13.0M YoY-51.9% | 27.0M | |
| Pre-tax income | 2.77B YoY+7.2% | 2.58B YoY+9.3% | 2.36B YoY-6.0% | 2.51B YoY-12.6% | 2.88B | |
| Income tax | 614M YoY+15.6% | 531M YoY-28.5% | 743M YoY+32.0% | 563M YoY-6.2% | 600M | |
2.08B YoY+4.6% | 1.99B YoY+27.1% | 1.57B YoY-18.2% | 1.92B YoY-14.7% | 2.25B | ||
$4.55 YoY+4.8% | $4.34 YoY+43.2% | $3.03 YoY-28.2% | $4.22 YoY-14.7% | $4.95 | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
12.5B YoY+26.3% | 9.90B YoY+5.2% | 9.41B YoY+13.1% | 8.32B | — | ||
36.9B YoY+11.5% | 33.1B YoY+2.0% | 32.5B YoY+17.8% | 27.5B | — | ||
9.11B YoY-4.7% | 9.55B YoY+6.4% | 8.98B YoY+24.9% | 7.19B | — | ||
26.3B YoY+7.7% | 24.4B YoY-2.8% | 25.1B YoY+40.1% | 17.9B | — | ||
10.4B YoY+22.9% | 8.45B YoY+18.4% | 7.13B YoY-23.8% | 9.36B YoY-43.9% | 16.7B | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
1.99B YoY+1.6% | 1.96B YoY-6.9% | 2.10B YoY-1.5% | 2.13B YoY+32.8% | 1.61B | ||
-1.05B YoY-14.6% | -914M YoY-63.8% | -558M YoY-40.2% | -398M YoY+77.4% | -1.76B | ||
617M YoY+207.7% | -573M YoY-19.9% | -478M YoY+41.8% | -822M YoY-212.5% | -263M | ||
| FX effect on cash | 66.0M YoY+185.7% | -77.0M YoY-670.0% | -10.0M YoY-233.3% | -3.00M YoY+91.2% | -34.0M | |
| Net change in cash | 1.62B YoY+319.4% | 387M YoY-63.3% | 1.05B YoY+18.5% | 890M YoY+297.3% | -451M | |
| Interest paid | 522M YoY-5.1% | 550M YoY-3.5% | 570M | 0.00 YoY-100.0% | 21.0M | |
| Income taxes paid | 429M YoY-12.6% | 491M YoY+3.6% | 474M YoY-44.3% | 851M YoY+38.4% | 615M | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 37.4B YoY+4.6% | 35.7B YoY+1.5% | 35.2B | — | — | |
| P/E | 17.9× YoY+0.0% | 17.9× YoY-12.3% | 20.4× | — | — | |
| P/S | 1.8× YoY-0.2% | 1.8× YoY-0.4% | 1.8× | — | — | |
| P/B | 3.6× YoY-14.9% | 4.2× YoY-14.2% | 4.9× | — | — | |
| P/FCF | 24.8× YoY+8.0% | 23.0× YoY+14.0% | 20.2× | — | — | |
| Earnings yield | 5.6% YoY-0.0% | 5.6% YoY+14.1% | 4.9% | — | — | |
| FCF yield | 4.0% YoY-7.4% | 4.4% YoY-12.3% | 5.0% | — | — | |
| Dividend yield | 0.2% YoY+6.8% | 0.2% YoY+3.0% | 0.2% | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: GEHC's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all GEHC filings on SEC EDGAR → Not investment advice.
